图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
肿瘤形成评论综述™
SJR: 0.946 SNIP: 0.503 CiteScore™: 2

ISSN 打印: 0893-9675
ISSN 在线: 2162-6448

肿瘤形成评论综述™

DOI: 10.1615/CritRevOncog.v15.i1-2.40
pages 91-115

Structural and Expression Changes of Septins in Myeloid Neoplasia

Nuno Cerveira
Department of Genetics, Portuguese Oncology Institute, Portugal
Joana Santos
Department of Genetics, Portuguese Oncology Institute, Porto, Portugal
Manuel R. Teixeira
Department of Genetics, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; and Abel Salazar Biomedical Sciences Institute (ICBAS), Porto, Portugal

ABSTRACT

Septins are an evolutionarily conserved family of GTP-binding proteins that associate with cellular membranes and the actin and microtubule cytoskeletons. Fourteen septin genes have been characterized to date (SEPT1 to SEPT14) in humans. Septins have been reported to be misregulated in various human diseases, including neurological disorders, infection, and neoplasia. In this review, we describe what is known thus far about septin deregulation in myeloid neoplasia. Septin abnormalities in myeloid neoplasia can be divided into two major groups. First, some septins (SEPT2, SEPT5, SEPT6, SEPT9, and SEPT11) have been repeatedly identified as in-frame fusion partners of the MLL gene in de novo and therapy-related myeloid neoplasia, in both children and adults. Second, deregulation of the expression of septin family genes in hematological cancers can be observed either with or without the concomitant presence of MLL gene fusions. Although current hypotheses regarding the roles of septins in oncogenesis remain speculative for the most part, the fundamental roles of septins in cytokinesis, membrane remodeling, and compartmentalization can provide some clues on how abnormalities in the septin cytoskeleton could be involved in neo-plastic disorders.


Articles with similar content:

Aberrant B-Raf Signaling in Human Cancer − 10 Years from Bench to Bedside
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Michael Roring, Tilman Brummer
Determining Omics Spatiotemporal Dimensions Using Exciting New Nanoscopy Techniques to Assess Complex Cell Responses to DNA Damage: Part B− Structuromics
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 3
Lenka Stefancikova, Marie Davidkova, Abin Biswas, Jan Sevcik, Michal Hofer, Anna Michaelidesova, Iva Falkova, Emilie Lukasova, Michael Hausmann, Alena Bacikova, Zdenek Kleibl, Alla Boreyko, Pavel Matula, Jana Vachelova, Stanislav Kozubek, Evgeny Krasavin, Martin Falk, Lucie Jezkova, Georg Hildenbrand
The Cbl Protooncogene Product: From an Enigmatic Oncogene to Center Stage of Signal Transduction
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 2-3
Patrice Douillard, Mark L. Lupher, Jr., Nancy L. Lill, Satoshi Ota, Christopher E. Andoniou, Hamid Band, Navin Rao, Sachiko Miyake
Determining Omics Spatiotemporal Dimensions Using Exciting New Nanoscopy Techniques to Assess Complex Cell Responses to DNA Damage: PART A−Radiomics
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 3
Lenka Stefancikova, Marie Davidkova, Abin Biswas, Jan Sevcik, Michal Hofer, Anna Michaelidesova, Iva Falkova, Emilie Lukasova, Michael Hausmann, Alena Bacikova, Zdenek Kleibl, Alla Boreyko, Pavel Matula, Jana Vachelova, Stanislav Kozubek, Evgeny Krasavin, Martin Falk, Lucie Jezkova, Georg Hildenbrand
Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Yu Qin, Lynn Gordon, Madhuri Wadehra, Shabnam Mohandessi